Related by context. All words. (Click for frequent words.) 76 Patient Outcomes 76 Venous Thromboembolism 76 Acute Ischemic Stroke 75 Carotid Stenting 75 Ischemic Stroke 75 Rheumatoid Arthritis Patients 74 Elderly Patients 74 Percutaneous Coronary Intervention 74 Combination Treatment 74 Newly Diagnosed Multiple Myeloma 74 Acute Myocardial Infarction 74 Patients Undergoing 74 Heart Failure Patients 73 Septic Shock 73 Acute Coronary Syndrome 73 Infarction 73 Survival Benefit 73 Prospective Randomized 73 Cardiovascular Events 73 Overactive Bladder 73 Pulmonary Arterial Hypertension 72 Localized Prostate Cancer 72 Stent Thrombosis 72 Subgroup Analysis 72 Adjuvant Chemotherapy 72 Severe Asthma 72 Chronic Heart Failure 72 Patients Receiving 72 Advanced Melanoma 72 Cardiovascular Outcomes 72 Severe Sepsis 72 ST Elevation Myocardial 72 Statin Therapy 72 Unstable Angina 72 Abciximab 72 Hemodialysis Patients 72 Metastatic Prostate Cancer 72 Obese Patients 71 Randomized Controlled Trials 71 ST Segment Elevation 71 Pediatric Patients 71 Improves Survival 71 Unfractionated Heparin 71 Renal Cell Carcinoma 71 Neoadjuvant Chemotherapy 71 Fracture Risk 71 Improve Outcomes 71 Diabetic Patients 71 Dual Antiplatelet Therapy 71 Gastric Cancer 71 Myocardial Ischemia 71 Improves Outcomes 71 Allergic Rhinitis 71 Hospitalized Patients 71 Clinical Outcome 71 Reduces Mortality 71 Colorectal Cancer Patients 71 Oral Fingolimod 71 Thrombolysis 71 Randomized Trials 71 Cardiac Resynchronization 71 Cognitive Impairment 70 Myocardial Infarction 70 Adjuvant Therapy 70 Lung Injury 70 Advanced Prostate Cancer 70 Left Ventricular Dysfunction 70 Controlled Trial 70 Estrogen Therapy 70 Prolongs Survival 70 Chronic Hepatitis C 70 Antiplatelet Therapy 70 Meets Primary Endpoint 70 Patients Treated 70 Platelet Inhibition 70 Relapsing Multiple Sclerosis 70 Minimally Invasive Treatment 70 Pooled Analysis 70 Improved Survival 70 Postmenopausal Women 70 Improve Survival 70 Patients Treated With 70 Castration Resistant Prostate Cancer 70 Advanced Pancreatic Cancer 70 Bare Metal Stents 70 Inflammatory Markers 70 Breast Cancer Recurrence 70 Liver Failure 70 Treated Patients 69 Renal Impairment 69 Fungal Infections 69 Hormone Receptor Positive 69 Phase III Clinical Trial 69 Critically Ill Patients 69 Clostridium difficile Infection 69 Ventricular Arrhythmias 69 Bivalirudin 69 Prostate Cancer Patients 69 Nesiritide 69 Renal Function 69 Metastatic Renal Cell Carcinoma 69 Solid Tumors 69 Randomized Clinical Trial 69 Hip Fracture 69 Osteoarthritis Patients 69 Meta Analysis 69 Treatment Naive Patients 69 Knee Osteoarthritis 69 Myelodysplastic Syndromes 69 Risk Stratification 69 Long Term Efficacy 69 Cardiogenic Shock 69 Phase III Trial 69 Intracerebral Hemorrhage 69 Acute Decompensated Heart Failure 69 Appears Safe 69 Fondaparinux 69 Non Responders 69 Study Evaluating 69 Hypertensive Patients 69 Metabolic Disorder 69 Benign Prostatic Hyperplasia 69 Depressive Symptoms 69 Bone Metastases 69 Disease Progression 69 Randomized Controlled 69 Coronary Artery Bypass Graft 69 Bloodstream Infections 69 Prophylactic Treatment 69 Predict Risk 69 Clinical Trial Results 69 Stent Restenosis 69 Beta Blockers 69 Autologous Stem Cell Transplantation 69 Ischemic 69 Ranolazine 69 Multicenter Trial 69 Urinary Incontinence 69 Mitral Regurgitation 68 Acute Heart Failure 68 Chronic Hepatitis B 68 Acute Pancreatitis 68 Partial Onset Seizures 68 Resistant Hypertension 68 See CLINICAL PHARMACOLOGY 68 Bipolar Depression 68 Patients Suffering 68 Randomized Evaluation 68 Artery Disease 68 Adverse Event 68 Thromboembolism 68 Hepatocellular Carcinoma 68 Well Tolerated 68 Orthostatic Hypotension 68 Investigational Drug 68 Decompensated Heart Failure 68 Phase 2b Clinical Trial 68 Relapsed Multiple Myeloma 68 Osteoporosis Drugs 68 Multiple Myeloma Patients 68 Organ Rejection 68 Randomized Controlled Trial 68 Adjunctive 68 Hyperlipidemia 68 Acute Myocardial 68 Increased Mortality 68 Mortality Risk 68 Carotid Endarterectomy 68 Serious Infections 68 Hypercholesterolemia 68 Prognostic Value 68 Antiplatelet 68 Catheter Ablation 68 Post Operative 68 Newly Diagnosed Breast Cancer 68 Hospital Acquired Pneumonia 68 Invasive Breast Cancer 68 Kidney Function 68 Myeloma Patients 68 Clinical Trial Evaluating 68 Demonstrates Positive 68 Guideline Update 68 Complicated Skin 68 Nebulized 68 Infarct 68 Prevent Stroke 68 Sleep Disturbances 68 Clinical Efficacy 68 Phase IIb Trial 68 Relapsing Remitting Multiple Sclerosis 68 Radiofrequency Ablation 68 Genes Predict 68 Insulin Glargine 68 Chronic Bronchitis 68 Boosts Survival 68 Chronic Renal Failure 68 Drug Eluting Stents 68 Diabetic Foot Ulcer 68 Diabetic Nephropathy 68 Blood Cancers 68 Chronic Sinusitis 68 Lupus Nephritis 68 Juvenile Idiopathic Arthritis 68 Antitumor Activity 68 Randomized Clinical Trials 68 Significantly Improved 68 Monotherapy 68 Comorbidities 68 Psychiatric Disorders 68 Survival Rates 68 Major Depressive Disorder 67 Treating Chronic 67 JAK Inhibitor 67 Left Ventricular 67 Antipsychotic 67 Glycemic Control 67 Chemoradiation 67 Hepatitis C Virus 67 Demonstrates Sustained 67 Uterine Fibroids 67 Liver Metastases 67 Brain Metastases 67 Renal Cell Carcinoma RCC 67 Demonstrates Significant 67 Stent Implantation 67 Cutaneous T 67 Phase 2b Study 67 Cardiotoxicity 67 Venous Thrombosis 67 Shows Efficacy 67 Tiotropium 67 Valve Replacement 67 Secondary Hyperparathyroidism 67 Diabetic Neuropathy 67 Coronary Angiography 67 Vascular Disease 67 Investigational Treatment 67 Adjunctive Therapy 67 Combo Therapy 67 Statistically Significant 67 Hormone Refractory Prostate Cancer 67 Pivotal Trial 67 Clinical Outcomes 67 Radical Prostatectomy 67 Malignant Melanoma 67 Phase IIb Clinical Trial 67 Lung Cancer Patients 67 Less Invasive 67 Treatment Outcome 67 Clinical Evaluation 67 Cognitive Function 67 Previously Treated 67 Reduced Risk 67 Recurrent Stroke 67 Renal Anemia 67 Novel Oral 67 Slow Progression 67 Diabetic Neuropathic Pain 67 Neoadjuvant 67 ACE Inhibitors 67 Breast Density 67 Clinical Trial Data 67 Phase 2b Trial 67 Multicenter Study 67 Fewer Side Effects 67 Is Well Tolerated 67 Schizophrenia Treatment 67 Non Alcoholic Fatty 67 Treatment Reduces 67 Inhaled Nitric Oxide 67 Thrombotic 67 Progressive Multifocal Leukoencephalopathy 67 Nymox NX 67 Prostate Biopsy 67 Endometrial Cancer 67 Significantly Reduced 67 STRIDE PD 67 Enlarged Prostate 67 Versus Placebo 67 HER2 Positive Breast Cancer 67 Proven Effective 67 Chronic Myeloid Leukemia 67 Lung Function 67 Medication Errors 67 Brain Aneurysms 67 First Patient Treated 67 Combination Therapy 67 Lung Cancer Trial 67 Anticoagulant 67 Valsartan 67 HCV Protease Inhibitor 67 Cholesterol Levels SPARCL 67 Genetic Markers 67 Naive Patients 67 Advanced Ovarian Cancer 67 Total Knee Arthroplasty 67 Clopidogrel 66 Skin Lesions 66 Hemorrhagic Stroke 66 Androgen Deprivation Therapy 66 Unresectable 66 Cholesterol Lowering Drug 66 Placebo Controlled Trial 66 Left Ventricular Hypertrophy 66 Premature Infants 66 Randomized Study 66 Insulin Therapy 66 Lupus Drug 66 Tumor Growth 66 Breast Tumors 66 J Am Coll 66 Antipsychotic Drug 66 Dialysis Outcomes 66 Stenting 66 Breast Cancer Treatment 66 Advanced Colorectal Cancer 66 Aortic Stenosis 66 Outpatient Setting 66 Kidney Transplant Patients 66 Platelet Aggregation 66 Anti Clotting Drug 66 Surgical Procedures 66 Antihypertensive 66 Suicidality 66 Anticoagulants 66 Effective Than 66 Randomised Trial 66 Breast Cancer Patients 66 Kidney Failure 66 Subtypes 66 Emerging Therapies 66 Systematic Review 66 Renal Artery 66 Prognostic Significance 66 Prospective Multicenter 66 Metastatic Colorectal Cancer 66 Anxiety Depression 66 Stem Cell Transplants 66 Recurrent Breast Cancer 66 Percutaneous Tibial Nerve Stimulation 66 Randomized Double Blind 66 Potentially Fatal 66 CABG Surgery 66 Drug Shows Promise 66 ANN INTERN MED 66 Suicidal Ideation 66 Preterm Delivery 66 Initiates Clinical Trial 66 Migraine Headaches 66 Significantly Reduces 66 Postmenopausal Osteoporosis 66 Atopic Dermatitis 66 Valvular Heart Disease 66 Investigational Agent 66 Refractory Angina 66 Breast Cancers 66 Invasive Fungal Infections 66 Dialysis Patients 66 Surgical Treatment 66 Generalized Anxiety Disorder 66 Cardiovascular Risk Factors 66 Lipid Lowering 66 Hypotension 66 Long Term Survival 66 Myocardial Infarction Study 66 Phase III Trials 66 Novel Antibiotic 66 Tumor Response 66 Respiratory Distress 66 Periodontal Disease 66 Demonstrates Efficacy 66 Adverse Outcomes 66 CT Angiography 66 First Patient Enrolled 66 Preclinical Data 66 Brain Atrophy 66 Dyslipidemia 66 Gout Patients 66 Hip Fractures 66 Medication Adherence 66 Lung Cancers 66 Restenosis 66 Refractory Hodgkin Lymphoma 66 Drug Eluting 66 Unstable angina 66 Heart Transplant Recipients 66 Inhaled Corticosteroids 66 Cardiovascular Disease Risk 66 Randomized Phase II 66 Sirolimus Eluting Stent 66 Gene Variation 66 Treatment Regimen 66 Insulin Resistance 66 Blocked Arteries 66 Sustained Reduction 66 Diabetic Kidney Disease 66 Epilepsy Drug 66 Diabetic Foot Ulcers 66 Virus Infection 66 Physical Function 66 Prostate Cancer Recurrence 66 Chronic Insomnia 66 Renal Insufficiency 66 Prostate Cancer Treatment 66 Chronic Constipation 66 Soft Tissue Sarcoma 66 Pivotal Phase III 66 Implantable Cardioverter Defibrillators 66 Blood Clots 66 Coronary Artery 66 Dose Escalation 66 Treating Depression 66 Gene Linked 66 Contrast Agent 66 Patient Enrollment 65 Anthracycline 65 Laryngeal Cancer 65 FDA Approvals 65 Investigational Compound 65 Pivotal Phase 65 Seasonal Allergic Rhinitis 65 Prognostic Factors 65 Hepatitis C Genotype 65 Rectal Cancer 65 Gene Mutation 65 Critical Limb Ischemia CLI 65 Coronary Artery Calcium 65 Relapsed Refractory 65 Study Showed 65 Drug Prevents 65 Panic Disorder 65 Pivotal Clinical Trial 65 Cardiac Resynchronization Therapy 65 Menopausal Women 65 Adjuvant Treatment 65 #-# Full Text 65 Newly Diagnosed 65 NDA Submission 65 Plaque Psoriasis 65 Severe Acne 65 Metastatic Melanoma 65 Intracranial Aneurysms 65 Adverse Effects 65 Completes Enrollment 65 ARCOXIA 65 Aggressive Prostate Cancer 65 invasive aspergillosis 65 Fibromyalgia Pain 65 Contrast Agents 65 Bare Metal Stent 65 Bone Mineral Density 65 Stable Angina 65 Renal Cancer 65 Lowers Risk 65 Obese Teens 65 Bipolar Mania 65 Primary Hypercholesterolemia 65 Topline Results 65 Embolic Protection Device 65 Occlusive Disease 65 Skeletal Muscle 65 Migraine Pain 65 Catheter Associated 65 Uterine Fibroid Embolization 65 Shows Promising 65 Drug Coated Stents 65 Demonstrated Significant 65 Carotid Artery Stenting 65 Placebo Controlled Study 65 Iron Deficiency 65 Cardiovascular Risk 65 Antipsychotic Medications 65 Gout Drug 65 Phase Ib Clinical Trial 65 Therapy Reduces 65 Functional Outcomes 65 Premenopausal Women 65 Hepatotoxicity 65 Hepatitis C Infection 65 Disease Modifying 65 Cognitive Problems 65 Spinal Manipulation 65 Hormone Replacement 65 Sustained Efficacy 65 Peginterferon 65 Reduce Mortality 65 Inhaled Steroids 65 Gastric Bypass Surgery 65 Diagnostic Criteria 65 Ovarian Cancer Patients 65 Proves Effective 65 Genes Associated 65 Single Dose 65 Ischaemic 65 Double Blind Placebo 65 undergoing Percutaneous Coronary 65 Study Demonstrates 65 Score TOS 65 Total Knee Replacement 65 Angioedema 65 NATRECOR R 65 Osteoporosis Drug 65 Beta Blocker 65 Autoimmune Diseases 65 Acute Migraine 65 Regimens 65 Symptom Relief 65 RE LY ® 65 ARIXTRA 65 Phase IIa Clinical Trial 65 Shown Effective 65 Corticosteroid 65 Aortic Valve Replacement 65 Nonalcoholic Fatty Liver Disease 65 Treatment Experienced 65 acute coronary syndromes ACS 65 Phase III Clinical Trials 65 Lung Cancer Survival 65 Acute Renal Failure 65 Aggressive Reduction 65 Randomized Double Blind Placebo 65 Infected Patients 65 Acute Coronary 65 Disease Severity 65 Systemic Sclerosis 65 Bone Marrow Cells 65 Angiographic 65 Liver Injury 65 Hyperkalemia 65 Anticoagulation 65 Acute Coronary Syndromes ACS 65 stable angina 65 Successfully Treated 65 Double Blind Randomized 65 Preclinical Study 65 Complication Rates 65 Drug Combo 65 Improved Outcomes 65 Sleep Disordered Breathing 65 Long Term Outcomes 65 Anticancer Drugs 65 Shows Promise Against 65 Demonstrate Significant 65 Diabetic Macular Edema 65 Renal Tumors 65 Antiviral Activity 65 Platinol ® 65 Improves Quality 65 Obesity Linked 65 Microalbuminuria 64 PEGINTRON TM 64 Brain Scans 64 Oral Mucositis 64 REACH Registry 64 Radiation Dose 64 Ventricular Tachycardia 64 Implantable Cardioverter Defibrillator 64 ADHD Medication 64 Pegylated Liposomal Doxorubicin 64 J Clin 64 Orally Active 64 Treating Heart Failure 64 unfractionated heparin UFH 64 Guidelines Issued 64 Peripheral Arterial Disease 64 Bone Fracture 64 Cholesterol Levels 64 Advanced Solid Tumors 64 Cancer Recurrence 64 Valvular 64 Iron Overload 64 Eluting Stent 64 Phase 2a Clinical Trial 64 Diastolic Heart Failure 64 ORLive Presents 64 Eye Diseases 64 Differential Diagnosis 64 Study Shows Benefits 64 Pulmonary Arterial Hypertension PAH 64 Anemia Drug 64 Natalizumab 64 antiplatelet medications 64 Gene Variants 64 Transplant Patients 64 Phase 2a Trial 64 Fixed Dose 64 Statin Drugs 64 Who Underwent 64 Hormone Therapy 64 Suicidal Behavior 64 Lung Cancer Drug 64 Systemic Lupus Erythematosus SLE 64 Pelvic Organ Prolapse 64 Anti Tumor 64 Breast Carcinoma 64 Cause Mortality 64 Drug Candidate 64 Blood Pressure Reduction 64 Novel Mechanism 64 Inflammatory Disease 64 Migraine Headache 64 Patency 64 Asthma Treatment 64 Controlled Study 64 Patients Enrolled 64 Reduces Risk 64 Increases Risk 64 Retinal Vein Occlusion 64 Deep Venous Thrombosis 64 Mouse Model 64 Nicotine Vaccine 64 Prostate Surgery 64 Inflammatory Diseases 64 Bone Fractures 64 stable angina pectoris 64 Advanced Renal Cell 64 Endothelial Function 64 Antifungals 64 Aortic Dissection 64 Treatment Resistant 64 Completes Patient Enrollment 64 Embolic Protection 64 Gene Variant 64 Endovascular Repair 64 ischemic complications 64 Genetic Tests 64 Inflammatory Arthritis 64 gefitinib Iressa 64 Genes Linked 64 CLARITY TIMI 64 Significant Reduction 64 Community Acquired Pneumonia 64 Cardiometabolic 64 Hip Fracture Risk 64 Bladder Cancer 64 Adenoma 64 Aortic Aneurysm 64 ACUITY trial 64 FASLODEX 64 entitled Formulary Advantages 64 Thrombolytic Therapy 64 Initiates Enrollment 64 Val HeFT 64 Circulating Tumor Cells 64 Prolongs Life 64 Minimally Invasive Procedure 64 Atherothrombosis 64 Intracranial 64 Initiate Clinical Trial 64 Data Suggest 64 Non Invasive Treatment 64 Postmenopausal 64 Prostate Cancers 64 Increased Risk 64 Coronary Revascularization 64 Intervention Effectiveness 64 Hematological Cancers 64 Node Positive 64 See WARNINGS 64 Prospective Randomized Trial 64 CLINICAL PHARMACOLOGY 64 Levels Linked 64 nicardipine 64 Arterial Disease 64 Showed Significant 64 Novel Compound 64 Low Dose 64 Anti Tumor Activity 64 Chemotherapeutic Agents 64 Sexual Function 64 Efficacy Trial 64 Vertebral Fracture 64 induce orthostatic hypotension 64 NAVISTAR R 64 Balloon Angioplasty 64 Gastrointestinal Disorders 64 Chronic Liver Disease 64 Menopausal Symptoms 64 Dose Ranging Study 64 Acute Exacerbations 64 Endovascular Treatment 64 Excessive Sweating 64 Enoxaparin 64 Blood Pressure Drug 64 Coronary Artery Bypass Grafting 64 Myelofibrosis 64 Spectrum Pharmaceuticals Announces 64 Interferon Beta 64 Tyrosine Kinase Inhibitor 64 Protease Inhibitor 64 Phase III Pivotal 64 Mayo Clinic Study Finds 64 Robotic Assisted 64 Acute Stroke 64 Hepatitis C Treatment 64 Effective Treatments 64 Regenerative Cells 64 Nonalcoholic Steatohepatitis 64 Colorectal Cancers 64 Severely Obese 64 achieved CCyR 64 Cancer Patients Treated 64 Systolic Blood Pressure 64 Coronary Atherosclerosis 64 Telithromycin 64 Drug Reactions 64 Active Rheumatoid Arthritis 64 Pivotal Study 64 Vertebral Compression Fractures 64 Abdominal Pain 64 Heart Failure Therapies 64 alfuzosin 64 Genes Involved 64 Intravenous Formulation 63 Genetic Defect 63 Hemolysis 63 Radiation Induced 63 Follicular Lymphoma 63 Prostatectomy 63 Treatment Shows Promise 63 Urinary Tract Infections 63 Randomized Phase III 63 Subarachnoid hemorrhage 63 receiving VELCADE 63 Glatiramer Acetate 63 Lipid Lowering Treatment 63 Statin Use 63 Insulin Sensitivity 63 Lymphoma Patients 63 Carotid Artery 63 Protein Linked 63 Carotid Revascularization Endarterectomy vs. 63 Antidepressant Use 63 Novel Therapies 63 Vertebral Fractures 63 Psychiatric Illness 63 Heartburn Drugs 63 RENAL 63 UA NSTEMI 63 Plus Ribavirin 63 Trial Evaluating 63 Cervical Dysplasia 63 Renal dysfunction 63 Elevated Levels 63 Embolization 63 Progenitor Cells 63 Albuminuria 63 Stroke Risk 63 venlafaxine Effexor 63 aldosterone antagonist 63 HER2 Positive 63 Cholesterol Drugs 63 Life Threatening 63 Stress Incontinence 63 Diuretic 63 Aortic Valve 63 Asthma Symptoms 63 Antidepressant Treatment 63 Darbepoetin Alfa 63 Thyroid Hormone 63 Randomized Double blind 63 Thyroid Cancer 63 Pneumococcal Vaccine 63 Dupuytren Contracture 63 Viral Load 63 EURIDIS 63 Teva Provides Update 63 ACTEMRA TM 63 RNAi Therapeutics 63 Demonstrates Potent 63 myocardial infarction ventricular fibrillation 63 Colorectal Adenomas 63 Acute Pain 63 Atrial 63 Hernia Repair 63 Treatment Naïve 63 Viral Suppression 63 Trandolapril 63 Spinal Fusion 63 Atypical Hemolytic Uremic Syndrome 63 Immune Responses 63 Phospholipase A2 63 Cell Lymphoma 63 ARIXTRA R 63 Confirms Efficacy 63 Peptic Ulcer 63 Brain Tumors 63 II Clinical Trial 63 Gender Differences 63 Atypical Antipsychotics 63 Arrhythmias 63 Pain Relievers 63 Kidney Transplantation 63 Thromboembolic 63 Malignancies 63 Study Shows Significant 63 Growth Hormone Deficiency 63 Often Misdiagnosed 63 Cocaine Addiction 63 Vaginal Gel 63 Prospective Cohort Study 63 Bosutinib 63 Node Negative 63 Significantly Improves 63 Zoledronic Acid 63 Gestational Diabetes 63 Neuroendocrine Tumors 63 Comorbid 63 Anticancer Activity 63 Mg Usa 63 Coronary Disease 63 FDA Approves Drug 63 Non Alcoholic Steatohepatitis 63 Non Inferiority 63 Total Hip Arthroplasty 63 Intervention Trial 63 Medication Compliance 63 Antidepressants Linked 63 Malignant Glioma 63 Newly Diagnosed Patients 63 Cancer Treatments 63 Antipsychotic Drugs 63 Hepatitis C Patients 63 Recurrent Prostate Cancer 63 Kidney Transplant Recipients 63 Asthma Attacks 63 atherothrombotic disease 63 Rotavirus Vaccine 63 Randomized Phase 63 Respiratory Virus 63 Radiation Exposure 63 Pegylated Interferon 63 Pulmonary Artery 63 Bypass Surgery 63 Clinical Practice Guidelines 63 VIIBRYD 63 Breast Tissue 63 Sudden Cardiac Death 63 MRSA Infections 63 Oral Calcitonin 63 STRATEGY FOR AN OPEN 63 Opioid Use 63 Cardiac Biomarkers 63 Screening Mammography 63 Treat Heart Failure 63 Inflammatory Bowel Diseases 63 Hospitalization Rates 63 Coronary Artery Bypass Surgery 63 Gastrointestinal Stromal Tumors 63 Blood Pressure Lowering 63 Reperfusion Injury 63 Stent Placement 63 Watchful Waiting 63 Congestive Heart Failure 63 Idiopathic Pulmonary Fibrosis 63 Gastric Ulcers 63 Asymptomatic 63 Left Atrial 63 REMINDER ORLive Presents 63 Aromatase Inhibitors 63 Immunomedics Announces 63 Malignant Pleural Mesothelioma 63 Impaired Glucose Tolerance 63 Epidermal Growth Factor Receptor 63 Safinamide 63 Targeted Therapy 63 Previously Untreated 63 NMIBC 63 Interventional Procedures 63 Drug Resistant 63 Spinal Fractures 63 Aneurysm Repair 63 Complete Remission 63 HeFH 63 Ambulatory Blood Pressure 63 Statistical Significance 63 Preterm Infants 63 Evaluation WISE 63 FDA Okays 63 Treat Anemia 63 Multicenter Phase 63 ExTRACT TIMI 63 Antibiotic Treatment 63 Multicenter 63 Genetic Mutations 63 Lipid Levels 63 Peginterferon Alfa 2a 63 NATRECOR ® 63 Coronary Arteries 63 Reperfusion 63 Expanded Indication 63 Coronary Artery Disease 63 Cholesterol Drug 63 Cardiovascular Mortality 63 Initiates Phase III 63 Autoimmune Disorders 63 Cypher Sirolimus 63 R lenalidomide 63 INTEGRILIN R 63 Metabolic Efficiency 63 Male Infertility 63 ALN HPN 63 Esophageal Cancer 63 Psoriasis Patients 63 Cell Transplants 63 Smallpox Vaccination 63 Neuroprotective Effects 63 Osteoarthritis Pain 63 Unmet Medical 63 sertraline Zoloft 63 Genes Identified 63 Osteoporosis Treatment 63 Gemzar ® 63 Afib 62 Genetic Variation 62 Fecal Incontinence 62 cilostazol 62 Coronary Syndromes 62 Preterm Labor 62 Dementia Patients 62 Metastatic Pancreatic Cancer 62 Pharmacologic 62 Prophylaxis 62 Leukemias 62 Contrast Enhanced 62 Multicenter Randomized 62 Carotid 62 Therapy Improves 62 Etiology 62 Antibiotic Use 62 Benign Prostatic Hyperplasia BPH 62 Cognitive Decline 62 Myelodysplastic Syndrome 62 Rheumatoid 62 Chronic HCV 62 dual endothelin receptor antagonist 62 Heart Failure Treatment 62 ORENCIA ® 62 Critical Limb Ischemia 62 Allogeneic 62 Tigecycline 62 Irritable Bowel 62 prospective multicentre 62 NICE SUGAR 62 Severity MSCS score 62 Preclinical Models 62 Novel Therapeutic 62 Systolic Hypertension 62 ATACAND 62 Receives Orphan Drug Designation 62 PRADAXA 62 Interferon beta 1a 62 IIIa inhibitor 62 ZOLINZA 62 Liver Damage 62 Erythropoietic 62 Neuropathic Pain 62 Physician Insights 62 AA Amyloidosis 62 Chemotherapy Improves 62 Lymph Node 62 Orphan Diseases 62 Lowering Blood Pressure 62 Sleep Duration 62 Initiate Phase II 62 aldosterone antagonists 62 Treatment Naive HIV 62 Adalimumab 62 Antithrombotic 62 Blood Pressure Drugs 62 Peripheral Vascular Disease 62 Decompensated 62 Limb Ischemia 62 Pregnancy Linked 62 Acne Drug 62 Hemoglobin Levels 62 Therapeutic Efficacy 62 Clot Busting 62 Heterozygous Familial Hypercholesterolemia 62 B Cell Malignancies 62 Tolerability 62 deep venous thromboses 62 Postoperative Ileus 62 Transdermal Patch 62 Capsule Endoscopy 62 Therapeutic Potential 62 Pharmacokinetic Study 62 acute coronary syndromes 62 First Patient Dosed 62 Efficacious 62 citalopram Celexa 62 Bronchopulmonary Dysplasia 62 Blood Transfusions 62 Paroxysmal Nocturnal Hemoglobinuria PNH 62 Therapy Evaluation 62 Cognitive Deficits 62 Eculizumab 62 Thiazolidinediones 62 Peripheral Arterial